<DOC>
	<DOCNO>NCT02681978</DOCNO>
	<brief_summary>This study evaluate effect ivabradine endothelial function patient coronary artery disease ( CAD ) complete revascularization percutaneous coronary angioplasty ( PCI ) . At least 30 day PCI , patient randomize receive ivabradine 5 mg twice daily continue standard medical therapy .</brief_summary>
	<brief_title>Ivabradine Improve Endothelial Function Patients With Coronary Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>history stable coronary disease complete coronary revascularization PCI least 1 month prior recruitment sinus rhythm absence anginal symptom rest heart rate &lt; 60 beat per minute severe reduction leave ventricle ejection fraction ( &lt; 40 % ) coronary artery bypass surgery myocardial infarction , stroke cerebral transient ischemic attack within previous 6 month implant pacemaker , cardioverter , defibrillator sick sinus syndrome sinoatrial block congenital long QT complete atrioventricular block</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>